366 related articles for article (PubMed ID: 1837968)
1. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
[TBL] [Abstract][Full Text] [Related]
2. [Uptake and distribution of hematoporphyrin derivatives (HPD) in arteriosclerotic and normal vessel segments].
Gonschior P; Goetz AE; Gonschior GM; Groh J; Höfling B
Z Kardiol; 1991 Jul; 80(7):435-40. PubMed ID: 1833890
[TBL] [Abstract][Full Text] [Related]
3. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
Winther JB
Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
[TBL] [Abstract][Full Text] [Related]
4. [Time resolved laser fluorescence microscopy of hematoporphyrin derivative in vivo].
Feyh J; Goetz A; Schneckenburger H; Müller W; Kastenbauer E
Laryngorhinootologie; 1991 Jan; 70(1):41-4. PubMed ID: 1827265
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic effect in an experimental bladder tumor treated with intratumor injection of hematoporphyrin derivative.
Lin CW; Amano T; Rutledge AR; Shulok JR; Prout GR
Cancer Res; 1988 Nov; 48(21):6115-20. PubMed ID: 2971434
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy for the prevention of intimal hyperplasia in balloon-injured rabbit arteries.
Usui M; Asahara T; Naitoh Y; Katoh T; Ibukiyama C
Jpn Circ J; 1999 May; 63(5):387-93. PubMed ID: 10943619
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fluorescence and photodynamic activities of whole hematoporphyrin derivative and its enriched active components.
Nelson JS; Wright WH; Berns MW
J Natl Cancer Inst; 1985 Dec; 75(6):1135-40. PubMed ID: 2933546
[TBL] [Abstract][Full Text] [Related]
8. Longer term assessment of photodynamic therapy for intimal hyperplasia: a pilot study.
Cheung J; Todd M; Turnbull R; Allison B; Mornin L; Carvalho AM; Spurr G; Hsiang Y
J Photochem Photobiol B; 2004 Feb; 73(3):141-7. PubMed ID: 14975402
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
El-Far M; Pimstone N
Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
[TBL] [Abstract][Full Text] [Related]
10. Effects of hematoporphyrin derivative and photodynamic therapy on atherosclerotic rabbits.
Litvack F; Grundfest WS; Forrester JS; Fishbein MC; Swan HJ; Corday E; Rider DM; McDermid IS; Pacala TJ; Laudenslager JB
Am J Cardiol; 1985 Oct; 56(10):667-71. PubMed ID: 2931972
[TBL] [Abstract][Full Text] [Related]
11. Effects of photosensitizer (hematoporphyrin derivative-HPD) and light dose on vascular targets in the albino mouse ear.
Davis RK; Davis K; Straight RC; Waner M
Laryngoscope; 1988 Jan; 98(1):1-4. PubMed ID: 3336250
[TBL] [Abstract][Full Text] [Related]
12. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
[TBL] [Abstract][Full Text] [Related]
13. Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.
Little FM; Gomer CJ; Hyman S; Apuzzo ML
J Neurooncol; 1984; 2(4):361-70. PubMed ID: 6241630
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of esophageal varices: experimental studies in animal veins, and first clinical cases.
Li CZ; Cheng LF; Wang ZQ; Gu Y
Endoscopy; 2003 Dec; 35(12):1043-8. PubMed ID: 14648419
[TBL] [Abstract][Full Text] [Related]
15. Histopathological comparison of the effects of hematoporphyrin derivative on two different murine tumors using computer-enhanced digital video fluorescence microscopy.
Nelson JS; Wright WH; Berns MW
Cancer Res; 1985 Nov; 45(11 Pt 2):5781-6. PubMed ID: 4053049
[TBL] [Abstract][Full Text] [Related]
16. [Hematoporphyrin derivative-mediated photodynamic therapy for human nasopharyngeal carcinoma: a comparative study with CNE2 and C666-1 cell lines in vitro].
Yang XM; Luo RC; Ma HJ; Li LB; Ding XM; Yan X; Lü CW; Zhou XP
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):165-7. PubMed ID: 17355926
[TBL] [Abstract][Full Text] [Related]
17. [Topical administration of hematoporphyrin derivative and red light irradiation. A therapeutic approach in psoriasis].
Monfrecola G; Mangone S; Procaccini EM; Santoianni P
G Ital Dermatol Venereol; 1988 Dec; 123(12):671-4. PubMed ID: 2978159
[No Abstract] [Full Text] [Related]
18. [History of photodynamic therapy--past, present and future].
Kato H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):8-15. PubMed ID: 8546474
[TBL] [Abstract][Full Text] [Related]
19. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
[TBL] [Abstract][Full Text] [Related]
20. [Percutaneous absorption of hematoporphyrin derivative--fluorescence- and electron microscopic studies].
Preś H; Meffert H; Barthelmes H; Klug H; Sönnichsen N
Dermatol Monatsschr; 1990; 176(8):461-8. PubMed ID: 2146175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
